Effects of E2/P4 oral capsules on bone turnover in women with vasomotor symptoms

OBJECTIVE: To evaluate bone turnover markers (BTM) in the REPLENISH trial (NCT01942668). METHODS: REPLENISH evaluated oral estradiol/progesterone (E2/P4) for the treatment of moderate to severe vasomotor symptoms (VMS) in postmenopausal women with a uterus. Eligible women for this analysis had ≥50 m...

Descripción completa

Detalles Bibliográficos
Autores principales: McClung, Michael R., Kagan, Risa, Graham, Shelli, Bernick, Brian, Mirkin, Sebastian, Constantine, Ginger
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Original Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8862769/
https://www.ncbi.nlm.nih.gov/pubmed/35213517
http://dx.doi.org/10.1097/GME.0000000000001915

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8862769/
https://www.ncbi.nlm.nih.gov/pubmed/35213517
http://dx.doi.org/10.1097/GME.0000000000001915

Ejemplares similares